| |
|
|
|
Aeglea BioTherapeutics Inc.  
|
|
7.71 0.1 (0.01%) |
09-21 11:35 |
|
Open: |
7.59 |
Pre close: |
7.61 |
Target:
|
9.16 
|
|
High: |
7.84 |
Low: |
7.51 |
Resistance:
|
7.84
9.16
|
|
Volume: |
122,770 |
Market Cap: |
378M |
Support:
|
6.94
6.39
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.36
|
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
7.25 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
6.94  |
Stochastic Oscillator |
%K(14,3):
|
80.82 |
|
MA(250): |
7.54 |
%D(3): |
64.19 |
|
Average Volume(K) |
3-Month: |
14561
|
52-Week |
High:
|
9.90 |
|
10-Days: |
20865 |
Low: |
5.82 |
|
RSI |
RSI(14):
|
62.63 |
Change(%): |
11.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.520 |
Return on Equity (ttm) |
-80.9 |
Shares Out. (M) |
49.02 |
|
EPS Est. Current Year |
-2.070 |
Return on Assets (ttm) |
-41.6 |
Shares Float (M) |
29.17 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.51 |
|
EPS Est. Next Quarter |
-0.580 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
92.35 |
|
Forward EPS |
-2.450 |
Gross Profit (p.s.) |
-1.217 |
Shares Short (K) |
2180 |
|
Book Value (p.s.) |
2.920 |
EBITDA (p.s.) |
-1.642 |
P/E |
-5.03 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.62 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-75.78 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-50.80 |
P/CF |
-4.94 |
|
|
|
|
|
|
